{"id":"https://openalex.org/W3043505992","doi":"https://doi.org/10.1128/aac.00579-20","title":"Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia","display_name":"Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia","publication_year":2020,"publication_date":"2020-07-16","ids":{"openalex":"https://openalex.org/W3043505992","doi":"https://doi.org/10.1128/aac.00579-20","mag":"3043505992","pmid":"https://pubmed.ncbi.nlm.nih.gov/32690640","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7508610"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00579-20","doi":"https://doi.org/10.1128/aac.00579-20","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00579-20","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7508610","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040537266","display_name":"Abla Tannous","orcid":"https://orcid.org/0000-0002-4668-0246","observed_orcids":["https://orcid.org/0000-0002-4668-0246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abla Tannous","raw_affiliation_strings":["BioAegis Therapeutics, North Brunswick, New Jersey, USA"],"raw_orcid":"https://orcid.org/0000-0002-4668-0246","affiliations":[{"raw_affiliation_string":"BioAegis Therapeutics, North Brunswick, New Jersey, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068074009","display_name":"Susan L. Levinson","orcid":"https://orcid.org/0000-0001-7902-1274","observed_orcids":["https://orcid.org/0000-0001-7902-1274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan L. Levinson","raw_affiliation_strings":["BioAegis Therapeutics, North Brunswick, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioAegis Therapeutics, North Brunswick, New Jersey, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032780756","display_name":"James A. Bolognese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I95746587","display_name":"Cytel (United States)","ror":"https://ror.org/01ftkxq60","country_code":"US","type":"company","lineage":["https://openalex.org/I95746587"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Bolognese","raw_affiliation_strings":["Cytel Corporation, Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cytel Corporation, Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I95746587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025379878","display_name":"Steven M. Opal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven M. Opal","raw_affiliation_strings":["Alpert Medical School of Brown University, Providence, Rhode Island, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alpert Medical School of Brown University, Providence, Rhode Island, USA","institution_ids":["https://openalex.org/I27804330"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062571783","display_name":"Mark J. DiNubile","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark J. DiNubile","raw_affiliation_strings":["BioAegis Therapeutics, North Brunswick, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioAegis Therapeutics, North Brunswick, New Jersey, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8758,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.7236688,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":98},"biblio":{"volume":"64","issue":"10","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.9463000297546387,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.02370000071823597,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/community-acquired-pneumonia","display_name":"community-acquired pneumonia","score":0.8650000095367432},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.734000027179718},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9380000233650208},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6800000071525574},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6269999742507935},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.6209999918937683},{"id":"https://openalex.org/keywords/non-intensive-care-unit-patients","display_name":"non-intensive care unit patients","score":0.7440000176429749},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8160207271575928},{"id":"https://openalex.org/C80722340","wikidata":"https://www.wikidata.org/wiki/Q18297560","display_name":"Gelsolin","level":3,"score":0.7816734313964844},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.6752800345420837},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6443116664886475},{"id":"https://openalex.org/C2776376669","wikidata":"https://www.wikidata.org/wiki/Q5094647","display_name":"Intensive care unit","level":2,"score":0.6187946200370789},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5268446207046509},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5180330872535706},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4783056080341339},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.44230738282203674},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12339138984680176},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06229093670845032},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0},{"id":"https://openalex.org/C125705527","wikidata":"https://www.wikidata.org/wiki/Q185269","display_name":"Actin","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017714","descriptor_name":"Community-Acquired Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018260","descriptor_name":"Gelsolin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.00579-20","doi":"https://doi.org/10.1128/aac.00579-20","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00579-20","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7508610","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7508610","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:32690640","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32690640","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7508610","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7508610","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1518972156","https://openalex.org/W1544976636","https://openalex.org/W1607612649","https://openalex.org/W1876413960","https://openalex.org/W1953105070","https://openalex.org/W1970976992","https://openalex.org/W1971156106","https://openalex.org/W1972257177","https://openalex.org/W2000714505","https://openalex.org/W2006773867","https://openalex.org/W2033056242","https://openalex.org/W2035194855","https://openalex.org/W2036178039","https://openalex.org/W2042944880","https://openalex.org/W2045797774","https://openalex.org/W2046713150","https://openalex.org/W2062077017","https://openalex.org/W2069521331","https://openalex.org/W2086991303","https://openalex.org/W2093054034","https://openalex.org/W2093730845","https://openalex.org/W2095147655","https://openalex.org/W2100125187","https://openalex.org/W2102361557","https://openalex.org/W2111061773","https://openalex.org/W2116347972","https://openalex.org/W2116426240","https://openalex.org/W2131857305","https://openalex.org/W2135635362","https://openalex.org/W2140717349","https://openalex.org/W2150963904","https://openalex.org/W2153125894","https://openalex.org/W2158474810","https://openalex.org/W2161167057","https://openalex.org/W2165210335","https://openalex.org/W2280404143","https://openalex.org/W2604164147","https://openalex.org/W2785493942","https://openalex.org/W2905335712","https://openalex.org/W2921476755","https://openalex.org/W2976022056","https://openalex.org/W2979938749","https://openalex.org/W2984009543","https://openalex.org/W3001118548","https://openalex.org/W3002108456","https://openalex.org/W3009885589","https://openalex.org/W3014666145","https://openalex.org/W3036785633","https://openalex.org/W4231485609","https://openalex.org/W4246308853","https://openalex.org/W4246883504","https://openalex.org/W6979074172"],"related_works":["https://openalex.org/W4287377238","https://openalex.org/W7143465919","https://openalex.org/W3036785633","https://openalex.org/W2959458350","https://openalex.org/W2905335712","https://openalex.org/W2760235031","https://openalex.org/W3173276712","https://openalex.org/W3014666145","https://openalex.org/W7214422582","https://openalex.org/W2105037209"],"abstract_inverted_index":{"There":[0],"remains":[1],"an":[2,246],"unmet":[3],"need":[4],"to":[5,53,237],"address":[6],"the":[7,66,72,76,90,128,157,174,179,218,223],"substantial":[8],"morbidity":[9],"and":[10,32,50,69,189,191,212],"mortality":[11],"associated":[12],"with":[13,208,250],"severe":[14],"community-acquired":[15],"pneumonia":[16,134],"(sCAP).":[17],"Recombinant":[18],"human":[19],"plasma":[20],"gelsolin":[21],"(rhu-pGSN)":[22],"improves":[23],"disease":[24],"outcomes":[25],"in":[26,65,71,115,127,135,164,178,198,222,233,245],"diverse":[27],"animal":[28],"models":[29],"of":[30,83,97,120,143],"infectious":[31],"noninfectious":[33],"inflammation.":[34],"This":[35],"blinded":[36],"dose-escalation":[37],"safety":[38],"study":[39,253],"involved":[40],"non-intensive":[41],"care":[42],"unit":[43],"(ICU)":[44],"patients":[45,235],"admitted":[46,236,249],"for":[47],"mild":[48,114],"CAP":[49,234],"randomized":[51],"3:1":[52],"receive":[54],"adjunctive":[55],"rhu-pGSN":[56,79,95,137,176,203],"or":[57,100,186],"placebo":[58,148,166],"intravenously.":[59],"Thirty-three":[60],"subjects":[61],"were":[62,112,161,183,195,215],"treated:":[63],"8":[64],"single-dose":[67,77,129,147],"phase":[68,130],"25":[70],"multidose":[73,91,158,180],"phase.":[74],"For":[75,89],"phase,":[78,92,159,181],"at":[80,257],"6":[81],"mg/kg":[82,102],"body":[84],"weight":[85],"was":[86,103,131,229],"administered":[87],"once.":[88],"a":[93,132,136,151,169,241],"daily":[94],"dose":[96],"6,":[98],"12,":[99],"24":[101],"given":[104],"on":[105],"3":[106],"consecutive":[107],"days.":[108],"Adverse":[109],"events":[110],"(AEs)":[111],"generally":[113],"both":[116],"treatment":[117],"groups":[118],"irrespective":[119],"dose.":[121],"The":[122,201],"only":[123],"serious":[124,185],"AE":[125,153],"(SAE)":[126],"non-drug-related":[133],"recipient":[138,149],"who":[139],"died":[140],"after":[141],"institution":[142],"comfort":[144],"care.":[145],"One":[146],"had":[150],"drug-related":[152,187],"(maculo-papular":[154],"rash).":[155],"In":[156,173],"there":[160,182],"2":[162,199,224],"SAEs":[163],"1":[165],"recipient,":[167],"including":[168],"fatal":[170],"pulmonary":[171],"embolism.":[172],"18":[175],"recipients":[177],"no":[184],"AEs,":[188],"nausea":[190],"increased":[192],"blood":[193],"pressure":[194],"each":[196],"reported":[197],"patients.":[200],"median":[202],"half-life":[204],"exceeded":[205],"17":[206],"h":[207],"all":[209],"dosing":[210,220,226],"regimens,":[211],"supraphysiologic":[213],"levels":[214],"maintained":[216],"throughout":[217],"24-h":[219],"interval":[221],"highest":[225],"arms.":[227],"Rhu-pGSN":[228],"well":[230],"tolerated":[231],"overall":[232],"non-ICU":[238],"beds,":[239],"justifying":[240],"larger":[242],"proof-of-concept":[243],"trial":[244],"ICU":[247],"population":[248],"sCAP.":[251],"(This":[252],"has":[254],"been":[255],"registered":[256],"ClinicalTrials.gov":[258],"under":[259],"identifier":[260],"NCT03466073.).":[261]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-07-23T00:00:00"}